News
Hyperinsulinemia Emerges as Critical Predictor of Severe Liver Outcomes
3+ hour, 30+ min ago (636+ words) Researchers have identified fasting hyperinsulinemia as a primary, yet often overlooked, driver of metabolic dysfunction-associated steatotic liver disease (MASLD). A new review published in Hepatology suggests that elevated insulin levels are not merely a symptom of metabolic syndrome but a…...
Continuous Glucose Monitoring Cuts Readmission Risks
1+ day, 3+ hour ago (662+ words) A new prospective study has found that initiating continuous glucose monitoring (CGM) at the point of hospital discharge is associated with significantly improved glycemic control and may halve the risk of hospital readmission for patients with type 2 diabetes. The research,…...
Beyond the Curve: How XLH Impacts Skeletal Maturation and Predicted Height
2+ day, 3+ hour ago (675+ words) New clinical research has identified a significant delay in skeletal maturation among children with X-linked hypophosphatemia (XLH), with male patients experiencing notably more pronounced delays than females. The study, published in Journal of The Endocrine Society, highlights a significant gap…...
Endocrine Society Advocacy Update - April 2026
3+ day, 2+ hour ago (275+ words) We will continue to keep members posted about funding'developments'and we will'participate'in an in-person Hill Day later this Fall as well." Urge Congress to Fund NIH for FY 2027; Join our New Online Advocacy Campaign' Congress is currently considering funding for fiscal…...
Pharma Friday - April 3, 2026
5+ day, 23+ hour ago (254+ words) On April 1, Eli Lilly and Company announced that the'U. S. Food and Drug Administration'(FDA) approved Foundayo" (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced-calorie diet and increased physical activity, Foundayo helps individuals…...
Could Moving Obesity Diagnosis Beyond BMI Delay Treatment?
1+ week, 2+ hour ago (459+ words) Endocrine Society shares concerns with The Lancet's obesity framework Redefining obesity based not only on body mass index (BMI) but on whether excess body fat is causing measurable health problems may complicate diagnosis and delay treatment, according to an Endocrine…...
Battling the Bulge: The War on Obesity
1+ week, 3+ day ago (833+ words) Once again, Endocrine News is devoting an issue to the obesity epidemic, but this year things don't look as dire as they have in past years. Yes, overweight and obesity is still running rampant around the world. That's the bad…...
Pharma Fridays - March 27, 2026
1+ week, 5+ day ago (405+ words) On March 26, Novo Nordisk announced that the US Food and Drug Administration (FDA) approved Awiqli" (insulin icodec-abae) injection 700 units/m L, the first and only once-weekly, long-acting basal insulin, indicated as an adjunct to diet and exercise to improve glycemic…...
When the Scale Isn't the Whole Story: Three Principles for Practicing Person-Centered Obesity Care
2+ week, 3+ hour ago (961+ words) Zeb I. Saeed, MD, a member of the steering committee for the Endocrine Society's Early Career Special Interest Group (SIG), shares with clinicians three patient-centric principles to treating overweight and obesity. As endocrinologists, we enter clinical practice having been well trained…...
Endocrine Society'Endorses'Bipartisan Bill'to Address Insulin'Affordability'
2+ week, 1+ day ago (590+ words) INSULIN Act would'expand'insulin'co-pay'cap to commercial market'and'encourage competition. The Endocrine Society'today endorsed'the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act,'a bipartisan'bill to address'insulin affordability'introduced by Sens. Jeanne Shaheen (D-NH),'Susan Collins (R-ME),'Raphael Warnock (D-GA), and'John Kennedy…...